Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Location
Ohio
Columbus
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
Apply
KRT-232 vs. BAT
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step